ASP Isotopes Inc. (ASPI)
NasdaqCM · Price as of · Nasdaq Real Time Price
- Profitability5/20
Losing money ($-117.3M over the last four reported quarters), but the top line is growing fast. Revenue over the last four reported quarters was $30.9M, up 558% from $4.7M the year before. Growth this quick earns partial credit; it still has to turn into profit.
- Insider buying vs selling8/20
Insiders are sellers only: 21 sells worth $6.2M, no open-market buys, across the last 19 Form 4s. Routine executive selling is common, so this is only a mild negative.
- Dilution and offerings1/15
Share count up 66.8% in a year and 4 offering-related filings. Heavy dilution. One nuance: offerings raise cash that can fund real growth. The score docks the certain near-term dilution; if the spending pays off, it shows up later in the profitability component.
- Analysts3
- Implied upside+292.7%
- Target range$11.00 to $15.00
- EPS expected-$0.13
- A year ago-$0.15
- Revenue expected$4.8M -1.2%
ASPI closed at $3.31 on Sep 11, down 23.0% since Aug 12. Chart read: price below both the 50-day and 200-day moving averages; the 50-day is below the 200-day (downtrend structure); trading at 0% of the 52-week range ($3.31 to $14.05).
Insider buying and selling at ASP Isotopes Inc. (ASPI)
The most recent Form 4 on record for ASP Isotopes Inc. (ASPI) is September 4, 2026, when Paul Elliot Mann, Chairman and CEO, sold $999,237 of stock. Those shares went automatically to cover tax on a vest, so it was not a decision to sell.
| Insider | Action | Value | Date | Type |
|---|---|---|---|---|
| Paul Elliot Mann · Chairman and CEO | Sell | $999,237 | September 4, 2026 | No decision |
| Paul Elliot Mann · Chairman and CEO | Sell | $2.0M | June 3, 2026 | No decision |
| Paul Elliot Mann · Executive Chairman | Sell | $932,866 | December 3, 2025 | No decision |
| Paul Elliot Mann · Executive Officer | Sell | $1.1M | November 28, 2025 | Routine |
| Paul Elliot Mann · Chief Executive Officer | Sell | $1.4M | September 10, 2025 | No decision |
Filed notices to sell
A Form 144 is filed beforean insider sells restricted stock. The Form 4 reporting the completed trade isn't due until two business days after the sale, so these land first. They are intentions, not transactions.
| Insider | Value | Filed | Status | Type |
|---|---|---|---|---|
| Ainscow Robert · OFFICER | $126,396 | September 2, 2026 | Not yet reported | Routine |
| Mann Paul Elliot · DIRECTOR, OFFICER | $949,819 | September 2, 2026 | Executed | Routine |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 4 | September 10, 2026 | FORM 4 |
| 425 | September 9, 2026 | 425 |
| 425 | September 9, 2026 | FORM 425 |
| 8-K | September 8, 2026 | 8-K |
| 4 | September 4, 2026 | FORM 4 |
| 4 | September 4, 2026 | FORM 4 |
| 4 | September 4, 2026 | FORM 4 |
| 144 | September 2, 2026 | View on EDGAR |
Frequently asked questions
When does ASPI report earnings?
ASP Isotopes Inc. (ASPI) is scheduled to report quarterly results on November 12, 2026 (estimated). The 1-analyst consensus is -$0.13 per share on revenue of $4.8M for the quarter ending September 30, 2026, against -$0.15 and $4.9M a year earlier. The date is an estimate from past reporting patterns and can move until the company confirms it.
What do analysts expect for ASPI?
3 analysts cover ASP Isotopes Inc. (ASPI). The consensus rating is Strong buy. The average price target is $13.00, in a range of $11.00 to $15.00.
Are insiders buying or selling ASPI?
We track Form 4 filings for ASP Isotopes Inc. (ASPI). The activity listed on this page shows 5 qualifying sales. Each row is labelled Routine when the filer declared a pre-arranged 10b5-1 plan, Tax withholding when shares were sold automatically to cover the tax on a vest, or Own call when neither applies.
Where can I see ASPI SEC filings?
Recent filings are listed on this page, newest first. The latest is a 4 filed September 10, 2026.